Free Trial

Zimmer Biomet (ZBH) Stock Price, News & Analysis

Zimmer Biomet logo
$93.18 -1.72 (-1.81%)
Closing price 03:59 PM Eastern
Extended Trading
$93.90 +0.72 (+0.78%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Zimmer Biomet Stock (NYSE:ZBH)

Key Stats

Today's Range
$93.13
$95.60
50-Day Range
$90.22
$98.18
52-Week Range
$89.22
$116.71
Volume
1.31 million shs
Average Volume
1.83 million shs
Market Capitalization
$18.44 billion
P/E Ratio
20.62
Dividend Yield
1.03%
Price Target
$111.39
Consensus Rating
Hold

Company Overview

Zimmer Biomet Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

ZBH MarketRank™: 

Zimmer Biomet scored higher than 99% of companies evaluated by MarketBeat, and ranked 23rd out of 778 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on 9 buy ratings, 9 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Zimmer Biomet has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Zimmer Biomet's stock forecast and price target.
  • Earnings Growth

    Earnings for Zimmer Biomet are expected to grow by 7.91% in the coming year, from $8.22 to $8.87 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zimmer Biomet is 20.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.50.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zimmer Biomet is 20.62, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.06.

  • Price to Earnings Growth Ratio

    Zimmer Biomet has a PEG Ratio of 2.18. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Zimmer Biomet has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Zimmer Biomet's valuation and earnings.
  • Percentage of Shares Shorted

    0.16% of the float of Zimmer Biomet has been sold short.
  • Short Interest Ratio / Days to Cover

    Zimmer Biomet has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zimmer Biomet has recently decreased by 99.78%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Zimmer Biomet pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Zimmer Biomet does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Zimmer Biomet is 21.24%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 10.82% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.

  • Read more about Zimmer Biomet's dividend.
  • Percentage of Shares Shorted

    0.16% of the float of Zimmer Biomet has been sold short.
  • Short Interest Ratio / Days to Cover

    Zimmer Biomet has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zimmer Biomet has recently decreased by 99.78%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Zimmer Biomet has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Zimmer Biomet this week, compared to 15 articles on an average week.
  • Search Interest

    8 people have searched for ZBH on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,000.00 in company stock.

  • Percentage Held by Insiders

    Only 1.39% of the stock of Zimmer Biomet is held by insiders.

  • Percentage Held by Institutions

    88.89% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zimmer Biomet's insider trading history.
Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

Zimmer Biomet (NYSE:ZBH) Upgraded at Roth Capital
Roth MKM upgrades Zimmer Biomet Holdings (ZBH) to a Buy
“All the land that you see I will give to you and your offspring forever…”
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More Headlines

ZBH Stock Analysis - Frequently Asked Questions

Zimmer Biomet's stock was trading at $105.63 at the beginning of 2025. Since then, ZBH stock has decreased by 11.8% and is now trading at $93.18.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) released its quarterly earnings data on Monday, May, 5th. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.77 by $0.04. The business's revenue was up 1.1% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Zimmer Biomet: Respondwell, Clinical Graphics, CD Diagnostics, Medtech SAS, Compression Therapy Products, LDR Holding, Cayenne Medical, and more.

Zimmer Biomet's top institutional shareholders include Douglas Lane & Associates LLC (0.20%), Gradient Investments LLC (0.09%), ST Germain D J Co. Inc. (0.06%) and QSM Asset Management Ltd (0.06%). Insiders that own company stock include Chad F Phipps, Sang Yi, Lori Winkler, Robert Hagemann, Michael W Michelson, Sreelakshmi Kolli and Betsy J Bernard.
View institutional ownership trends
.

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zimmer Biomet investors own include Chevron (CVX), Bristol Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Record date for 4/30 Dividend
3/31/2025
Ex-Dividend for 4/30 Dividend
3/31/2025
Dividend Payable
4/30/2025
Last Earnings
5/05/2025
Record date for 7/31 Dividend
6/26/2025
Ex-Dividend for 7/31 Dividend
6/26/2025
Today
7/18/2025
Dividend Payable
7/31/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:ZBH
Previous Symbol
NYSE:ZMH
CIK
1136869
Employees
17,000
Year Founded
1927

Price Target and Rating

High Price Target
$135.00
Low Price Target
$95.00
Potential Upside/Downside
+17.4%
Consensus Rating
Hold
Rating Score (0-4)
2.35
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.52
Trailing P/E Ratio
21.00
Forward P/E Ratio
11.55
P/E Growth
2.18
Net Income
$903.70 million
Net Margins
11.86%
Pretax Margin
13.65%
Return on Equity
12.73%
Return on Assets
7.34%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.44
Quick Ratio
1.46

Sales & Book Value

Annual Sales
$7.68 billion
Price / Sales
2.45
Cash Flow
$13.29 per share
Price / Cash Flow
7.14
Book Value
$62.67 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
197,850,000
Free Float
195,098,000
Market Cap
$18.78 billion
Optionable
Optionable
Beta
0.71

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSE:ZBH) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners